HemaCare Corp. (fka HEMA)

[snakess]

It appears that there are large buyer around. Either there is a takeover suitor or a fund cobbling up shares at a rapid pace. Since Oneblood
bought their position this stock has been on a upside tear. I believe that the numbers from year end are great and someone knows and the value
of the company has been mispriced. Rem when Oneblood bought initial position the stock was around $1 and Oneblood paid $3.44 early Jan Oneblood bought the 2nd tranche at the same price. One can only assume that their partnership has been extremely favorable so buyer are everywhere and the stock pushes higher. I assume the company is getting closer to filing for nasdaq listing. This will bring institutional investors on board and might even cause an IPO with a regional brokerage house in Cal and or New York.
In many cases investor's are always looking to get out , but with hema
investors are looking to get in. The majority of holders are not selling because HEMA offers cutting edge biotech for pharma and biopharma.
Year end numbers released in around 45 days.